North East and North Cumbria
ICS Formulary
ICS Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-03-02-02 Parenteral progestogen-only contraceptives
| Etonorgestrel 68mg implant Nexplanon® |
|
Formulary
|
|
 MHRA Drug Safety Update (Feb 2020): Nexplanon (etonogestrel) contraceptive implants: new insertion site to reduce rare risk of neurovascular injury and implant migration MHRA Drug Safety Update (June 2016): Nexplanon (etonogestrel) contraceptive implants: reports of device in vasculature and lung |
|
| Medroxyprogesterone Acetate injection |
|
Formulary
|
|
|
|
Links
- County Durham and Darlington Adult Bladder and Bowel formulary First Line Prescribing Guide 2023
- FSRH Standards & Guidance
- MHRA Drug Safety Update (Feb 2020): Nexplanon (etonogestrel) contraceptive implants: new insertion site to reduce rare risk of neurovascular injury and implant migration
- MHRA Drug Safety Update (June 2016): Nexplanon (etonogestrel) contraceptive implants: reports of device in vasculature and lung
- MHRA Drug Safety Update (March 2014): St John’s wort: interaction with hormonal contraceptives, including implants
- MHRA Drug Safety Update (March 2014): St John’s wort: interaction with hormonal contraceptives, including implants
- NICE CG30: Long-acting reversible contraception
- NICE NG118: Renal and ureteric stones: assessment and management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG126: Ectopic pregnancy and miscarriage: diagnosis and initial management
North of Tyne, Gateshead and North Cumbria Urinary Continence Enablement Products and Devices Formulary Guideline (October 2024)- Tees Urinary Continence Formulary February 2020